Clinical trial
Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients…
NCT00065507 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00065507 |
|---|---|
| Title | Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation |
| Official title | Comparison of the Efficacy and Safety of Entecavir Versus Adefovir in Subjects Chronically Infected With Hepatitis B Virus and Evidence of Hepatic Decompensation |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B |
| Intervention type | Drug |
| Interventions | Entecavir (ETV), Adefovir (ADV) |
| Enrollment | 195 |
| Start date | Aug 1, 2003 |
| Primary completion | Oct 1, 2008 |
| Completion | May 1, 2013 |
| First posted | Jul 29, 2003 |
| Last update posted | Jun 24, 2013 |
| Countries | Brazil, Canada, France, Greece, Hong Kong, India, Indonesia, Philippines, Poland, Russia, Singapore, South Africa and 5 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: